Cancer costs: Marketing and myth busting

More than half of cancer drugs approved in recent years may not be helping patients to live longer. Meanwhile, the average price of cancer drugs has been increasing by 10 percent annually for more...

Cracking the code of advanced prostate cancer

Understanding the tumor-specific alterations that are most important for prostate cancer aggressiveness and treatment decision-making will be the focus of a Marquam Hill...

Clearing the quandary of cancer early detection

For many cancers, five-year survival rates approach 99 percent if the disease is detected early, when tumors are small and not yet spreading. But efforts to detect cancers early have led to a...